Oslo, Norway ,December 14, 2023 -EXACT Therapeutics AS ("EXACT-Tx", Euronext Growth: EXTX), a clinical stage precision health company utilising Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, has been invited to give a presentation at the 14th AnnualDNB Nordic Healthcare Conference inOslo, Norway . Per Walday, Chief Executive Officer of EXACT Therapeutics, will present at the conference today,December 14, 2023 , at16:00 CET . The presentation will be made available at https://exact-tx.com/finreports About EXACT-Tx: EXACT-Tx is a Norwegian clinical-stage precision medicine company developing a technology platform for targeted therapeutic enhancement - Acoustic Cluster Therapy (ACT®). ACT® follows a unique approach to ultrasound-mediated, targeted drug enhancement - with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy) and brain diseases. www.exact-tx.com For more information, please contact: Per Walday, CEO EXACT Therapeutics Email per.walday@exact-tx.com
Click here for more information
© Oslo Bors ASA, source